Ubs Group Ag Aziyo Biologics, Inc. Transaction History

Ubs Group Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	32,079 Added 6415.8%	32,579 $47,000
Q1 2023 May 12, 2023	SELL	$1.19 - $4.96 $655 - $2,732	-551 Reduced 52.43%	500 $0
Q4 2022 Feb 08, 2023	BUY	$3.48 - $8.94 $1,259 - $3,236	362 Added 52.54%	1,051 $4,000
Q3 2022 Nov 10, 2022	BUY	$5.72 - $7.76 $1,063 - $1,443	186 Added 36.98%	689 $5,000
Q2 2022 Aug 10, 2022	SELL	$5.75 - $7.41 $6,066 - $7,817	-1,055 Reduced 67.72%	503 $4,000
Q1 2022 May 16, 2022	SELL	$4.31 - $7.58 $56 - $98	-13 Reduced 0.83%	1,558 $9,000
Q4 2021 Feb 14, 2022	SELL	$4.1 - $6.82 $237 - $395	-58 Reduced 3.56%	1,571 $10,000
Q3 2021 Nov 15, 2021	SELL	$6.75 - $9.52 $3,051 - $4,303	-452 Reduced 21.72%	1,629 $11,000
Q2 2021 Aug 13, 2021	BUY	$9.51 - $13.97 $2,130 - $3,129	224 Added 12.06%	2,081 $20,000
Q1 2021 May 12, 2021	BUY	$13.08 - $16.41 $9,273 - $11,634	709 Added 61.76%	1,857 $26,000
Q4 2020 Feb 11, 2021	BUY	$10.77 - $14.82 $12,363 - $17,013	1,148 New	1,148 $16,000

12.2M

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.